News: Hospira, Inc. (HSP.N)
49.01USD
1:34pm EST
$0.71 (+1.47%)
$48.30
$48.23
$49.01
$48.21
79,600
835,301
$49.90
$21.21
Wed, Dec 16 2009
Indian shares up 0.2 pct; Infosys hits record high
* Banks drop on worry cbank may tighten policy (Updates to close)
Indian shares edge down; banks fall, Infosys up
* Infosys up as official says better revenue growth in FY11
UPDATE 1-Hospira to buy Orchid generic injectable business
* $400 mln deal includes India manufacturing, R&D facility
UPDATE 4-Steel, rubber found in some Genzyme drugs
* Genzyme shares drop more than 7 percent (Updates with comments from company, analysts, FDA)
UPDATE 2-Fresenius Q3 profit up on higher generic drug sales
* Q3 adjusted net income 128 mln euros, vs forecast 123 mln
UPDATE 2-Hospira Q3 tops estimates; boosts outlook
* Adjusted Q3 profit beats analysts' consensus by 21 cents
UPDATE 3-U.S. FDA probing Abbott, Hospira device cords
* Risks include electrical shock, death - FDA (Adds Abbott comments)
Seoul shares seen up; eyes on BOK, LG Telecom
SEOUL, Oct 9 (Reuters) - Seoul shares may rise on Friday after gains overnight on Wall Street, but gains could be limited by caution before the Bank of Korea's interest rate decision and comments, with eyes also on the won <KRW=>.
UPDATE 1-Hospira in deal with Celltrion on biogenerics
* Deal on biogenerics in US, Europe, Australia, Canada, NZ
HEADLINE STOCKS-Some U.S. stocks on the move on Sept. 30
(Updates to add Hospira/Teva, ImmuCell, Orexigen, Omnova)
Press Releases
- Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
- Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business
- ChemGenex, Hospira, Announce Agreement to License, Develop and Commercialize Leukemia Drug in Europe
- Lancaster General Hospital Releases Infusion Pump/EHR Interoperability Data - Auto...
- Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers





